Fundraising Fox

Vtvtherapeutics

NASDAQ: VTVT

High Point, US · Delaware corporation · 2 known investors

vtvtherapeutics.com ↗

vTv Therapeutics is a biopharmaceutical company developing oral, small molecule drugs for diabetes and other chronic diseases. Its lead candidate, cadisegliatin, is a glucokinase activator in Phase 3 trials for treating type 1 diabetes.

BiotechDigital HealthMedical Devicesin /vtv_therapeutics@vTvTherapeutics

Founders & leadership

RH
Rudy HowardExecutive Officer
PM
Paul MeisterDirector
SH
Stephen HolcombeExecutive Officer
PS
Paul SavasDirector
NS
Noel SpiegelDirector
HW
Howard WeinerDirector
JF
John FryDirector
LA
Larry AltstielExecutive Officer
SC
Steven CohenDirector
CP
Craig ParkerDirector
JK
Jeffrey KindlerExecutive Officer, Director

Investors · 2

JDRF T1D FundBoston
Samsara BioCapitalPalo Alto

Reported raises · per SEC filings

Form D private placements
▶$51MraisedMar 2024 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith HarrisDirector
  • Steven TuchExecutive Officer
  • Srinivas AkkarajuDirector
  • Raymond CheongDirector
  • Richard NelsonExecutive Officer, Director
  • Paul J. SekhriExecutive Officer, Director
  • John A. FryDirector
  • Fahed Al MarzooqiDirector
  • Howard L. WeinerDirector
Offering amount
$51M
Amount sold
$51M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJan 2020 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rudy HowardExecutive Officer
  • Noel SpiegelDirector
  • Paul SavasDirector
  • John FryDirector
  • Stephen HolcombeExecutive Officer
  • Howard WeinerDirector
  • Jeffrey KindlerDirector
  • Hersh KozlovDirector
Offering amount
$10M
Amount sold
$2M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedOct 2019 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Howard WeinerDirector
  • Paul SavasDirector
  • John FryDirector
  • Hersh KozlovDirector
  • Jeffrey KindlerExecutive Officer, Director
  • Rudy HowardExecutive Officer
  • Stephen HolcombeExecutive Officer
  • Noel SpiegelDirector
Offering amount
$10M
Amount sold
$2M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedJul 2019 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey KindlerExecutive Officer, Director
  • Steven CohenDirector
  • John FryDirector
  • Paul SavasDirector
  • Howard WeinerDirector
  • Noel SpiegelDirector
  • Rudy HowardExecutive Officer
  • Stephen HolcombeExecutive Officer
Offering amount
$9M
Amount sold
$4M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJan 2019 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rudy HowardExecutive Officer
  • Howard WeinerDirector
  • Paul SavasDirector
  • Noel SpiegelDirector
  • Steven CohenDirector
  • Stephen HolcombeExecutive Officer
  • John FryDirector
  • Craig ParkerDirector
  • Jeffrey KindlerExecutive Officer, Director
Offering amount
$10M
Amount sold
$1.5M
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MofferedAug 2018 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Craig ParkerDirector
  • Howard WeinerDirector
  • Paul MeisterDirector
  • Stephen HolcombeExecutive Officer
  • Noel SpiegelDirector
  • Paul SavasDirector
  • Rudy HowardExecutive Officer
  • Steven CohenDirector
  • Jeffrey KindlerExecutive Officer, Director
  • John FryDirector
Offering amount
$10M
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedDec 2017 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rudy HowardExecutive Officer
  • Paul MeisterDirector
  • Stephen HolcombeExecutive Officer
  • Paul SavasDirector
  • Noel SpiegelDirector
  • Howard WeinerDirector
  • John FryDirector
  • Larry AltstielExecutive Officer
  • Steven CohenDirector
  • Craig ParkerDirector
  • Jeffrey KindlerExecutive Officer, Director
Offering amount
$10M
Amount sold
$10M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.